Skip to main content
Premium Trial:

Request an Annual Quote

Plasticell Completes $5.6M Financing Round

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Plasticell today said that it has completed a £3.5 million ($5.6 million) two-part equity financing.

The London-based maker of high-throughput technologies for directed stem cell differentiation, said that it will use the funds to expand its business development and marketing activities as it attempts to grow its customer base. The company has developed the CombiCult technology, which is used to develop stem cell differentiation protocols.

The first tranche of the financing, bringing in £1.5 million, was completed in April 2009. The most recent investment of £2 million was closed in December 2010. Plasticell did not name the investors in the round.

The company recently inked a collaboration with Sigma-Aldrich to combine their technologies in developing stem cell research tools. Plasticell also has collaborations with GlaxoSmithKline and UCB, it noted.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.